Jones Financial Companies
ELDN icon

Jones Financial Companies’s Eledon Pharmaceuticals ELDN Stock Holding History

Jones Financial Companies’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75.4K Buy
19,952
+4,952
+33% +$18K ﹤0.01% 2959
2026
Q1 		$42.5K Buy
+15,000
New +$35.3K ﹤0.01% 3001
2025
Q2 		– Sell
-725
Closed -$2.43K – 4063
2025
Q1 		$2.43K Buy
725
+100
+16% +$412 ﹤0.01% 3202
2024
Q4 		$2.58K Buy
+625
New +$2.46K ﹤0.01% 2939

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCM
Catalio Capital Management New York $532M AUM 166.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ZP
Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return

Jones Financial Companies's ELDN Position: Q2 2026 in Review

Jones Financial Companies increased its Eledon Pharmaceuticals (ELDN) stake by 33% in Q2 2026, buying an estimated $18K and bringing the position to 19,952 shares worth $75.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2959.

Jones Financial Companies first reported a position in ELDN in Q4 2024 and has held it in 4 quarters since. 160 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

  • Jones Financial Companies held 19,952 shares of Eledon Pharmaceuticals worth $75.4K as of Q2 2026.
  • Jones Financial Companies bought 4,952 Eledon Pharmaceuticals shares in Q2 2026, an estimated $18K.
  • Eledon Pharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #2959 holding.
  • Jones Financial Companies first reported a position in Eledon Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • 160 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.